Atlas Trials

Thiopurine EnhAnced Maintenance Therapy

Clinical trial NCT02912676 · COMPLETED

Trial details

NCT number
NCT02912676
Sponsor
Kjeld Schmiegelow
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Start date
2016-10-01
Primary completion
2020-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.